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INTRODUCTION
Abstract
AIM: To determine the predictive factors for early
aspiration in liver abscess.
METHODS: A retrospective analysis of all patients with
liver abscess from 1995 to 2004 was performed. Abscess
was diagnosed as amebic in 661 (68%) patients,
pyogenic in 200 (21%), indeterminate in 73 (8%) and
mixed in 32 (3%). Multiple logistic regression analysis
was performed to determine predictive factors for
aspiration of liver abscess.
RESULTS: A total of 966 patients, 738 (76%) male,
mean age 43 ± 17 years, were evaluated: 540 patients
r e s p o n d e d t o m e d i c a l t h e ra p y w h i l e a d j u n c t i ve
percutaneous aspiration was performed in 426 patients.
Predictive factors for aspiration of liver abscess were:
age ≥ 55 years, size of abscess ≥ 5 cm, involvement of
both lobes of the liver and duration of symptoms ≥ 7 d.
Hospital stay in the aspiration group was relatively longer
than in the non aspiration group. Twelve patients died in
the aspiration group and this mortality was not statistically
significant when compared to the non aspiration group.
CONCLUSION: Patients with advanced age, abscess
size > 5 cm, both lobes of the liver involvement and
duration of symptoms > 7 d were likely to undergo
aspiration of the liver abscess, regardless of etiology.
© 2008 WJG . All rights reserved.

Liver abscess, particularly due to amebiasis, is an important
clinical problem in tropical regions of the world and
accounts for a high number of hospital admissions[1-5]. It
is usually an easily treatable condition with good clinical
outcomes. There is however potential for morbidity and
even mortality if proper and timely treatment is not
provided[6-9]. The standard treatment of liver abscess is the
use of appropriate antibiotics and supportive care. Needle
aspiration can be used as an additional mode of therapy
and has been promoted by some authors for routine use
in the treatment of uncomplicated liver abscess. It is
suggested that needle aspiration can improve response
to antibiotic treatment, reduce hospital stay and the
total cost of treatment[10-12]. Although ultrasound guided
needle aspiration is fairly safe, it is nonetheless an invasive
procedure requiring the passage of a wide bore needle into
a highly vascular organ, and can be associated with the risk
of bleeding. Needle aspirations, especially at the time of
intervention has therefore remained a debatable issue and
it seems important to determine its possible role in the
treatment of liver abscess[13-16].
We have used a large database of patients admitted to
hospital with liver abscess in order to determine the factors
associated with the likelihood of liver abscess aspiration in
the treatment of patients with uncomplicated liver abscess.

MATERIALS AND METHODS
Medical records of all patients admitted to our hospital
with liver abscess over a ten-year period (Jan. 1995 to Dec.
www.wjgnet.com
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2004) were identified using the International classification
of diseases 9th revision with clinical modification (ICD9-CM-USA) and reviewed retrospectively. Patients with
complicated liver abscess, generally due to rupture of
abscess, were excluded from this analysis, as the indications
for needle aspiration in these patients are rather different
(Figure 1). Diagnosis of liver abscess was based upon
clinical history and abdominal ultrasound or CT scan
findings. The following data was collected in all the patients
who were diagnosed with uncomplicated liver abscess:
demographic information, chief complaint, duration of
fever or abdominal pain, associated illnesses, malignancy
and history of biliary surgery or other procedures. Results
of laboratory investigations and imaging studies done at
the time of admission were recorded as were the clinical
course of disease, modalities of treatments used and
outcome of the patients.
Patients with uncomplicated (non-ruptured) liver
abscess were underwent to the following investigations:
Complete blood counts, imaging by ultrasound, Indirect
Hem-agglutination Assay (IHA) for amebiasis, blood
culture and pus culture if the abscess was aspirated. IHA
was done with serology reagent “Cellognost Amebiasis”
supplied by (Dade Behring Marburg GmbH Germany) and
a titer of ≥ 1:128 was taken as diagnostic for amebic liver
abscess, as per the manufacturer’s recommendations. Based
upon the results of these investigations, patients with
liver abscess were categorized into four groups according
to the following criteria: (1) Amebic liver abscess (ALA):
IHA titer ≥ 1:128 with negative blood or pus culture. (2)
Pyogenic liver abscess (PLA): IHA titer < 1:32 with or
without positive blood and/or pus culture. (3) Mixed liver
abscess (MLA): IHA titer ≥ 1:128 with positive blood
and/or pus culture and (4) Indeterminate liver abscess
(ILA): IHA titer between 1:32 and 1:128 with negative
blood or pus culture. According to our usual practice,
patients were started on standard treatment of liver
abscess and if no clinical response was observed within
three days, therapeutic percutaneous needle aspiration
was carried out at the discretion of the treating physician.
Needle aspiration was done under local anesthesia and
ultrasound guidance without catheter drainage and the
procedure was repeated in 3-4 d if optimal response was
not obtained. Antibiotics were continued for 10-14 d for
ALA, 4-6 wk for PLA and mixed infection and 2-6 weeks
for indeterminate abscess.
Statistical analysis
A descriptive analysis was done for demographic, clinical
and radiographic features and results were presented
as mean ± SD for quantitative variables and number
(percentage) for qualitative variables. In univariate analyses,
differences in proportions for the group of patient
underwent to needle aspiration and no aspiration was done
by using the Chi-square test or Fisher exact test where
appropriate. One-way analysis of variance and independent
samples t-test were used to assess the difference of means
for contrasts of continuous variables. Multiple logistic
regression analysis was done and factors associated with
likelihood of abscess aspiration were identified.
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Total patients with liver abscess (1020)

Complicated cases excluded (54)
Uncomplicated liver abscess cases (966)

Pyogenic liver abscess (200)
Indeterminate liver abscess (73)
Amebic liver abscess (661)

Mixed liver abscess (32)

Uncomplicated liver abscess cases (966)

Aspiration done (426)

Medical therapy only (540)

Figure 1 Flow diagram of the patients with liver abscess and treatment received.

RESULTS
A total of 1020 patients with liver abscess were admitted
during the study period. Fifty four patients with
complicated liver abscess were excluded from the study
and 966 patients with uncomplicated liver abscess were
evaluated (Figure 1). The mean age was 43 ± 17 years
and 738 (76%) were males. The abscess was diagnosed as
amebic (ALA) in 661 (68%), pyogenic (PLA) in 200 (21%),
indeterminate (ILA) in 73 (8%) and mixed (MLA) in 32
(3%) patients. Clinical features of the patients in different
types of liver abscess are presented in Table 1. Five
hundred and forty patients responded to medical therapy
alone; adjunctive percutaneous aspiration was performed
in 426 patients. Demographic, clinical and laboratory
features of the two groups are compared in Tables 2-4.
There were significant differences between aspiration and
non aspiration groups for many covariates.
In the aspiration group, more patients were older
than 55 years (OR = 1.008; 95% CI = 1.0-1.01), duration
of symptoms was more than 7 d (OR=1.60; 95% CI =
1.21-2.11), they were more likely to be jaundiced (OR =
1.55; 95% CI = 1.18-2.17), have tender hepatomegaly (OR
= 0.68; 95% CI = 0.48-0.97) and hospital stay of more
than 5 d (OR = 2.99; 95% CI = 1.75-2.99), as compared to
the non-aspiration group (Table 2).
In the laboratory features the meaningful predictors of
aspiration were elevated total bilirubin (OR = 1.09; 95%
CI = 1.04-1.15), ALT (OR = 1.002; 95% CI = 1.0-1.004),
alkaline phosphatase (OR = 1.002; 95% CI = 1.001-1.003),
total leukocyte count (OR = 1.01; 95% CI = 1.004-1.03)
and platelet count (OR = 1.001; 95% CI = 1.0-1.002),
whereas relatively low serum albumin (OR = 0.59; 95%
CI = 0.44-0.80) was found in the aspiration group as
compared to the non aspiration group (Table 3).
The aspiration group, when compared with the nonaspiration group, was also found to have more patients
with abscess sizes larger than 5 cm (OR = 1.59; 95% CI
= 1.21-2.09), multiple abscesses (OR = 1.66; 95% CI =
1.23-2.24), involvement of both lobes of the liver (OR =
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Table 1 Clinical features of the patients with different types of
liver abscess n (%)
Characteristics

Table 3 Laboratory features of the patients with liver abscess
Characteristics
(mean ± SD)

Amebic
Pyogenic
Mixed Indeterminate P
abscess
abscess
abscess
abscess
value
(n = 661) (n = 200) (n = 32) (n = 73)

Gender
Male
568 (86)
Female
93 (14)
Age
< 55 yr
471 (71)
190 (29)
≥ 55 yr
Duration of symptoms1
453 (69)
≥7d
<7d
208 (32)
Jaundice (%)
No
534 (81)
Yes
126 (19)
Tender hepatomegaly
Yes
553 (84)
No
107 (16)
Diabetes mellitus
No
546 (83)
Yes
115 (17)
Treatment
Aspiration not
375 (57)
done
Aspiration done 286 (43)
Patient outcome
Alive
649 (98)
Died
12 (2)

158 (79)
42 (21)

27 (84)
5 (16)

66 (90)
7 (10)

146 (73)
54 (27)

25 (78)
7 (22)

52 (71)
21 (29)

136 (68)
64 (32)

24 (75)
8 (25)

47 (64)
26 (36)

170 (85)
30 (15)

26 (81)
6 (19)

64 (88)
9 (12)

179 (90)
21 (10)

26 (81)
6 (19)

57 (78)
16 (22%)

0.085

166 (83)
34 (17)

25 (78)
7 (22)

60 (82)
13 (18)

0.925

109 (54)

12 (37)

44 (60)

0.151

91 (46)

20 (63)

29 (40)

192 (96)
8 (4)

31 (97)
1 (3)

72 (99)
1 (1)

Total bilirubin
(mg/dL)
ALT (IU/L)
Alkaline
phosphatase (IU/L)
Albumin (g/L)
Serum creatinine
(mg/dL)
Leukocyte counts
(103/mm3)
Platelet counts
(103/mm3)

0.06

0.83
0.752

  20.09 ± 9.61

1.04-1.15 0.001

66.18 ± 75.9 1.002 1.000-1.004 0.010
86.8 ± 117.2 1.002 0.001-1.003 0.001
2.42 ± 0.6
1.25 ± 0.8
18.67 ± 8.03

0.590
1.130

0.44-0.80 0.001
0.99-1.28 0.070

1.010 1.004-1.030 0.010

357.69 ± 162.40a 328.33 ± 143.98 1.001 1.000-1.002 0.004

Characteristics

No. of abscess
Single abscess
Multiple abscesses
Site of lobe involvement
Right lobe
Left lobe
Both lobes
Presence of gallstones
Yes
No
Chest radiograph
Normal
Abnormal1
Size of abscess
≤ 5 cm
> 5 cm

0.352

Aspiration
Non
Odds 95% CI P
group
aspiration ratio
value
(n = 426)
group
(n = 540)
454 (84.1)
86 (15.9)

2.24 ± 0.50
1.37 ± 1.20

P

value

Table 4 Radiological features of patients with liver abscess (%)

Table 2 Clinical features of patients with liver abscess

365 (85.7)
61 (14.3)

81.29 ± 98.87
18.45 ± 141.3

95% CI

Variable compared to reference category (OR = 1), aP < 0.05; ALT: Alanine
aminotransferase.

Fever or abdominal pain.

Gender
Male
Female
Age
< 55 yr
≥ 55 yr
Duration of symptoms1 (n%)
<7d
≥7d
Jaundice (n%)
Yes
No
Diabetes mellitus (n%)
Yes
No
Patient outcome (n%)
Alive
Died
Hospital stay (n%)
<5d
≥5d

Non aspiration Odds
ratio
group
(n = 540)
1.86 ± 2.2
1.090

0.341

1

Characteristics

Aspiration
group
(n = 426)
2.55 ± 3.4

1.13 0.79-1.61 0.490
1.00

Aspiration Non aspiration Odds 95% CI P
group
group
ratio
value
(n = 426) (n = 540)
303 (71.1)
123 (28.9)a

434 (80.4)
106 (19.6)

1.00
1.66 1.23-2.24 0.001

301 (70.7)
59 (13.8)
66 (15.5)a

415 (76.9)
79 (14.6)
46 (8.4)

0.97 0.67-1.40
1.00
0.010
1.92 1.15-3.18

8 (1.9)a
418 (98.1)

11 (2.0)
529 (98.0)

0.92
1.00 0.36-2.30 0.860

235 (55.2)
191 (44.8)a

334 (61.9)
206 (38.1)

1.00
1.31 1.01-1.70 0.030

121 (28.4)
305 (71.6)a

209 (38.7)
331 (61.3)

1.00
1.59 1.21-2.09 0.001

1

282 (66.0) 412 (76.0)
144 (34.0)a 128 (24.0)

1.00
1.60

1.2-2.2

0.001

111(26.1) 195 (36.1)
315 (73.9)a 345 (63.9)

1.00
1.60 1.21-2.11 0.001

91 (21.4)a 80 (14.8)
335 (78.6) 459 (85.2)

1.55 1.18-2.17 0.009
1.00

70 (16.4)
356 (83.6)

99 (18.3)
441 (81.7)

0.87 0.62-1.22 0.440
1.00

414 (97.2)
12 (2.8)

530 (98.1)
10 (1.9)

1.00 0.65-3.59 0.320
1.53

126 (29.6) 265 (49.1)
300 (70.4)a 275 (50.9)

1.00
2.29 1.75-2.99 0.001

Variable compared to reference category (OR = 1), aP < 0.05; 1Fever or
abdominal pain.

1.92; 95% CI = 1.15-3.18) and abnormal chest X-rays (OR
= 1.31; 95% CI = 1.01-1.70) (Table 4).
Using multiple logistic regression, independent predictors

Raised right hemi diaphragm, pleural effusion, and right lung base
atelactasis. Variable compared to reference category (OR = 1), aP < 0.05.

for aspiration of liver abscess were age > 55 years, (OR = 1.6;
95% CI = 1.2-2.2), size of abscess more than 5 cm (OR = 1.6,
95% CI = 1.2-2.09), both lobes of the liver involvement (OR
= 2.2, 95% CI = 1.5-3.4) and duration of symptoms lasting
more than seven days (OR = 1.6, 95% CI = 1.2-2.1) (Table 5).
The number of abscesses ranged from 1-6 (median 2).
None of the patients with uncomplicated liver abscess
required surgery. In 403 (42%) patients, only one aspiration
session was done and in 23 (2%) patients, 2-3 aspiration
sessions were done before full recovery.
Twelve patients died in the aspiration group, although
this mortality was not statistically significant when compared
with the non aspiration group (Table 2). No deaths occurred
as a direct complication of the needle aspiration.

DISCUSSION
The use of needle aspiration in the treatment of uncomplicated liver abscess remains a debatable issue. Although
www.wjgnet.com
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Table 5 Independent predictors for aspiration of liver abscess
Factor
Age
< 55 yr
≥ 55 yr
Size of abscess
≤ 5 cm
> 5 cm
Location of abscess
One lobe
Both lobes
Duration of symptoms
<7d
≥7d

Coefficient Adjusted
95% CI for
Wald
odds ratio adjusted odds ratio P -value
0
0.5135

11
1.6

1.2-2.2

0.001

0
0.5324

11
1.6

1.2-2.09

0.001

0
0.7958

11
2.2

1.5-3.4

0.001

0
0.4542

11
1.6

1.2-2.1

0.001

The parameter coefficient, adjusted odds ratio, 95% CI and Wald P-value,
were estimated using multiple logistic regression. 1Reference category.

most of these patients respond to antibiotics and
supportive care, a significant number eventually require
needle aspiration which is generally done at a later stage,
while medical therapy alone is considered as inadequate,
resulting in an extended hospital stay[17-21].
An early decision regarding aspiration of liver abscess
is therefore important as it is likely to reduce the length
of hospital stay and hence the cost of treatment. On the
basis of patient characteristics at the time of presentation,
using a large data set, we have identified some factors that
are associated with aspiration of liver abscess irrespective
of the underlying etiology but we were unable to evolve a
model for aspiration with good power.
Most patients in this series also recovered completely
on appropriate antibiotics and supportive care. However
in a substantial number of patients, percutaneous needle
aspiration was additionally done for complete recovery.
Based upon a comparative analysis between the two
groups, patients who underwent aspiration were older,
had larger or multiple abscesses and longer duration of
symptoms than patients who recovered completely on
medical therapy alone. Underlying etiology of amebic,
pyogenic, mixed or indeterminate infection was not found
to be a determinant for aspiration.
This study also reflects the difficulties sometimes faced
by clinicians in determining the etiology of liver abscess.
In this series, 68% of the 966 patients were diagnosed to
have ALA, reflecting the burden of amebic infection in
tropical regions of the world[3].
The diagnosis of ALA is usually based on clinical and
radiological features along with a positive IHA Entameba
titer[1-3]. However none of these features are diagnostic
and, in clinical practice, confusion can often arise as to the
accurate diagnosis of ALA. For example a solitary abscess
in the right lobe of the liver is considered to be highly
suggestive of ALA[3,6,22], which was true for 79% of ALA
patients in this study. However a predominantly single
abscess involving the right lobe was also seen in 68% of
patients with PLA, suggesting that the presence of a single
right lobe abscess should not exclude the diagnosis of
PLA even in areas endemic for ALA. Similarly, although
multiple abscesses involving both lobes were present more
www.wjgnet.com
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commonly in patients with PLA[23-25], they were also seen
in 21% of patients with ALA.
The IHA Entameba titer is used to confir m the
diagnosis of ALA. A high titer of IHA in invasive
amebiasis is seen due to prolonged antigenic stimulation
of absorbed liver abscess material[2]. However some issues
should be considered when amoebic IHA is used in clinical
practice. There is firstly the problem inherent in any
serological assay, and that is the time lag required for the
test to become positive so that the first reading may not
achieve diagnostic values[2]. Secondly, in an endemic area,
the appropriate cut off value for a positive test needs to
be defined, keeping in mind the background positivity due
to repeated (sub clinical) exposures[1-3]. Titers of ≥ 1:128
were considered as diagnostic for ALA in this study, based
upon the manufacturer’s recommendations and current
literature[1,2]. However the higher the titer, the better is its
diagnostic value considered.
Patients with pyogenic liver abscess (PLA) in this study
has shown some differences in their clinical profile compared with other reported series; they were younger (mean
age of 43 ± 17 years) and the etiology was predominantly
cryptogenic[18,19].
Although gallstones were present more frequently
in PLA compared to patients with ALA, they were not
associated with ascending cholangitis in the present
series as reported previously[15,16]. The reasons for these
differences are not clear. However other reports also show
series of patients with PLA where the primary focus of
infection was not known[26-28].
Mixed abscess in this series comprised of 32 (3%),
similar to the 4%-5%. Prevalence repor ted in the
literature [20] . Mixed abscesses are basically ALA with
secondary bacterial infection and their outcome was similar
to ALA in the current series (Table 5) while in some studies
mixed abscess has high mortality[29,30].
Patients with indeterminate liver abscess behaved like
ALA as regards response to treatment and outcome of
disease. However the IHA titer failed to rise, even on
successive testing in some cases. This may be due to a
technical failure of the serological tests in these patients
for various reasons, including a depressed immune status.
In conclusion, based upon a retrospective analysis of a
large series of patients, we have found that if the patient
with liver abscess is older in age, the abscess is more than
5 cm in size, both lobes of the liver are involved and the
duration of symptoms is more than a week, then these
patients are more likely to undergo percutaneous aspiration
regardless of the etiology of abscess. A prospective study
to validate these observations is underway, and if found
accurate, it is likely to have an impact on cost effective
approaches and quality of life in the management of such
patients.
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